Kiai Parsa purchased $68K of MED (indirect holdings)
Kiai Parsa purchased 5,557 indirectly-held shares of MEDIFAST INC (MED) at $12.24 across 2 trades on 2026-10-28.
How this was made
The 30-second read
Why it matters
The director's purchase may be interpreted as a vote of confidence, but the modest $68K size limits market impact.
Market read
Insider buying is a modest positive signal for MED, unlikely to move the broader market.
What to watch
Potential upcoming corporate actions or earnings that prompted the insider purchase.
Background
Form 4 filings disclose insider transactions and are considered primary sources of material information.
Ticker impact
Director Kiai Parsa bought 5,557 shares of Medifast at $12.24 each, increasing his stake to 20,428 shares.
potential modest upward pressure as market absorbs insider buying
The purchase is a primary Form 4 filing, indicating new material information about insider confidence.
Market effects
Minimal impact on the health and nutrition sector; insider activity is company-specific.
Limited to US markets where MED trades.
Low; does not affect broader market trends.
Counterpoint
The small size of the purchase may be insignificant and could be routine portfolio rebalancing.
Key entities
- DirectorKiai Parsa
Director of Medifast who purchased shares.
- CompanyMedifast Inc
US-listed health and nutrition company (ticker MED).



